Super resolution imaging of nanoPMOs for cancer drug delivery
In recent years, nanomaterial-based various drug delivery carriers have been developed for the potential targeted cancer therapy. However, still the advanced study for optimization of size, shape, surface chemistry of the nanocarr...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
NANOSTORM
Design of Nanomaterials for Targeted Therapies Guided by Sup...
1M€
Cerrado
SNAP
Smart Nanomaterials with Applications in Photodynamic Therap...
30K€
Cerrado
UNAT
Ultra small Nanohybrides for Advanced Theranostics
833K€
Cerrado
BIO2013-41019-P
INGENIERIA DE NANOPARTICULAS PROTEICAS PARA LA ENTREGA DIRIG...
151K€
Cerrado
NANO4TARMED
Advanced hybrid theranostic nanoplatforms for an active drug...
745K€
Cerrado
PRE2018-086647
DISEÑO DE NANOPARTICULAS SILICEAS MESOPOROSAS PARA LA LIBERA...
93K€
Cerrado
Información proyecto MANTARGET
Duración del proyecto: 33 meses
Fecha Inicio: 2020-03-11
Fecha Fin: 2023-01-03
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
In recent years, nanomaterial-based various drug delivery carriers have been developed for the potential targeted cancer therapy. However, still the advanced study for optimization of size, shape, surface chemistry of the nanocarrier and observation of biological interaction and evaluation of such nanocarrier are not well-developed that limit their use for the efficient clinical applications. Therefore, superior understandings of the cellular interaction of the nanocarrier with different physicochemical properties are essential and challenging for improved the cancer treatments. In this project, we will focus on the optimization of different physicochemical properties of nanocarrier such as size, shape, surface chemistry and etc via investigation of its biological interaction and evaluation by a potent imaging technique. For this purpose, we will synthesize a library of efficient biodegradable drug delivery carrier periodic mesoporous organosilica nanoparticles (nanoPMOs) with
controlled size and shape and then functionalized with different targeting ligands with the controlled number per nanoparticle for mannose-6-phosphate receptor over-expressed prostate cancer. Then we will study the nanoPMOs-prostate cancer cell interactions, internalization pathway and intracellular degradation of nanoPMOs through the stochastic optical reconstruction microscopy (STORM). We will further evaluate the drug delivery efficacy of nanoPMOs and toxicity mechanism of drug loaded nanoPMOs to support microscopic observation. Thus the result of this biological interaction and evaluation of nanoPMOs with different physicochemical properties via super-resolution microscope STORM will help to develop a novel drug delivery carrier for prostate cancer therapy with optimal properties for clinical applications.